Safety, Tolerability and Pharmacodynamics Evaluation of CBT-009 Eye Drop

NCT05372991 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Myopia, Progressive

Interventions

DRUG: CBT-009
DRUG: Vehicle
DRUG: Atropine Sulfate

Sponsor

Cloudbreak Therapeutics, LLC

Collaborators

[object Object]